PDHA1 and breast carcinoma: These findings demonstrated that PDHA1 is a promising prognostic biomarker and actively takes part in the process of the immune response of breast cancer, thereby comprehensively shedding light on the exploitation of specific target drugs and immunegenic-mediated network of BC.